TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ARGX

argenx NV

Healthcare · Biotechnology

851.30$ -0.7% vs. previous close Closing price · As of: Aug 14, 2026

Statements

Balance Sheet

argenx NV (ARGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 10,032 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARGX
Line item Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q4 25 Q2 26
50 131 131 111 111 185 212 445 445 416 416 662 662 1,147 1,147 1,610 1,433 2,275 2,275 2,285 2,285 3,213 3,213 2,850 2,850 3,249 3,249 3,134 3,134 3,194 3,194 4,542 – 4,797 – 6,203 – 7,176 8,683 10,032
– 126 – 107 – 182 – 440 0.0 411 0.0 655 0.0 1,091 0.0 1,543 – 2,202 – 2,062 – 2,865 – 2,543 – 2,929 2,651 2,774 – 2,692 1,889 4,124 – 4,264 – 4,883 – 5,830 6,899 8,068
– 113 – 95 – 76 – 229 525 163 0.0 321 0.0 191 0.0 372 – 1,351 – 1,220 – 1,582 – 1,335 – 1,367 -2,651 801 – 1,111 -1,889 2,049 – 1,438 – 1,500 – 2,086 3,491 3,584
– 121 – 102 – 173 – 432 – 392 0.0 646 0.0 1,074 0.0 1,501 – 2,174 – 2,001 – 2,731 – 2,337 – 2,597 2,651 2,193 – 1,997 1,889 3,180 – 3,102 – 3,379 – 3,928 4,440 5,184
– 0.9 – 1.1 – 5.1 – 3.1 0.0 8.9 0.0 0.2 0.0 6.3 0.0 23 – 10 – 7.5 – 12 – 38 – 114 – 277 – 355 – 499 – 656 – 909 – 1,198 1,657 1,941
– 0.0 – 0.0 – 0.0 – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 -1.1 – 5.6 – 25 – 59 – 109 – 136 – 228 – 201 – 311 – 326 – 407 – 341 474 371
– – – 0.8 – 1.0 – 0.8 0.0 0.9 0.0 0.9 0.0 5.9 0.0 8.2 – 8.8 – 9.5 – 11 – 16 – 14 – 16 – 15 – – – – – – – – – –
– – – – – – – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 -4.8 – – – – – – – – – – – – – 16 – – – 9.4 – 6.3 – – – –
– 0.0 – 0.0 – 0.0 – 0.0 0.0 0.0 0.0 0.1 0.0 40 0.0 45 – 46 – 168 – 175 – 172 – 171 – 175 – 190 – 125 – 132 – 181 – 219 272 266
– 47 – 45 – 35 – 31 0.0 31 0.0 46 0.0 391 0.0 430 – 457 – 607 – 261 – 316 – 279 – 321 – 336 – 445 – 534 – 704 – 1,080 1,360 1,615
– 47 – 34 – 40 – 29 0.0 27 0.0 46 0.0 116 0.0 180 – 222 – 329 – 244 – 301 – 265 – 302 – 318 – 423 – 500 – 670 – 1,042 1,320 1,575
– – – – – – – – 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.2 – 2.5 – 3.5 – 3.5 – 3.5 – 3.5 – 3.4 – 3.2 – 4.6 – 5.9 – 6.5 – 7.6 11 11
– 5.7 – 13 – 15 – 5.3 0.0 25 0.0 6.9 0.0 63 0.0 96 – 144 – 207 – 239 – 293 – 167 – 189 – 195 – 246 – 281 – 342 – 532 1,267 718
– – – – – – – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – –
– 84 – 67 63 172 150 414 424 385 385 616 1,346 757 1,325 1,180 – 1,818 – 1,678 – 2,952 – 2,534 – 2,970 3,031 2,814 – 2,858 2,703 4,098 – 4,262 – 5,498 – 6,096 7,323 8,417
– -65 – -76 – -92 – -121 0.0 -144 0.0 -194 0.0 -244 0.0 -383 – -605 – -1,060 – -929 – -1,400 – -1,836 – -2,110 – -2,233 – -2,405 – -2,437 – -1,572 – -1,157 -280 558
16 17 26 20 26 22 32 27 32 32 40 34 40 40 40 39 43 47 50 50 50 54 51 52 52 53 55 55 56 56 58 58 59 59 66 71 66 66 66 64

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?